BioPharmSignal logoBioPharmSignal

Biotech News

Boston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 results

Boston Scientific (BSX)Boston ScientificEarnings

BSX (BSX) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is bsx.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Open original release

Related news

BSXBoston Scientific2026-03-30 12:00 EST

Boston Scientific announces conference call discussing first quarter 2026 results

BSXBoston Scientific2026-04-22 10:30 EST

Boston Scientific announces results for first quarter 2026

ICUIICU Medical2026-07-23 12:30 EST

ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call

EHCEncompass Health Corporation2026-07-09 20:30 EST

Encompass Health announces date of 2026 second quarter earnings call

DNLIDenali Therapeutics2026-07-27 20:01 EST

Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026

RXSTRxSight2026-05-06 20:05 EST

RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook

STIMNeuronetics2026-05-05 11:50 EST

Neuronetics Reports First Quarter 2026 Financial and Operating Results

PAVMPAVmed2026-05-01 12:31 EST

PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026

PAVMPAVmed2026-04-30 12:31 EST

Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026

CVRXCVRx2026-04-27 20:30 EST

CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026

View all latest news

Boston Scientific

Boston Scientific is a leading medical technology company with major exposure to interventional cardiology, electrophysiology, endoscopy, urology, and structural heart. The company is built around procedure-linked products that benefit from hospital utilization and physician adoption.

Recent company news

BSXBoston Scientific2026-05-19 10:31 EST

FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectiveness endpoints

BSXBoston Scientific2026-05-18 11:00 EST

Boston Scientific enters into $2 billion accelerated share repurchase agreement

BSXBoston Scientific2026-05-18 10:30 EST

Boston Scientific announces strategic investment in MiRus LLC

BSXBoston Scientific2026-05-04 12:00 EST

Boston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 results

BSXBoston Scientific2026-04-26 17:00 EST

Data at Heart Rhythm 2026 highlight key Boston Scientific therapies

Stock data

Close
45.51 USD
Market cap
70.87B USD
Exchange
NYSE
Sector
Biopharma
Location
United States